AGP Picks
View all

Palau Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palau Healthcare Times.

Press releases published on October 26, 2026

AI Is Reshaping Diabetes Care — From Drug Discovery to Continuous Monitoring
BayCare to Become First Health System in Florida to Pilot Robotic Blood-Draw Technology
MGMA Elects Audrey Fisher and Melanie Stohl as Directors-at-Large; Gena Graves as Vice Chair; Jeffrey Smith as Board Chair
LTC ACO Partner Summit Brings Long-Term Care Leaders Together to Turn Insight Into Action
Starryshine Named Best Dental Wholesale Supplier in California for 2026
Children's Choice Highlights Commitment to Expanding Access to Dental Care in San Diego
AnewHealth Awarded Joint Commission's Gold Seal of Approval® for Home Care Accreditation
Erdem Hospital Wins Two GIGI Awards for World Cup Connected TV Campaign
Seek Labs Expands Oncology Research for Sequence Ablation Therapeutics with Up to $3 Million in Foundation Support
New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model
Gene Therapy Market to Reach USD 36.55 Billion by 2032, Growing at a CAGR of 19.4% – MarketsandMarkets™
Academy and ASPHN Receive CDC Funding to Advance Nutrition Guidance for Infection Prevention
Neuro Cinnamon Capsules Introduces Neuro Cinnamon Multi-Ingredient Dietary Supplement Featuring Five Ingredients
CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance
Newsweek Places KFSH in Top 4% of World’s Smart Hospitals for Digital Maturity and AI
Kraig Labs Moves Beyond Bold Breakthrough
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
U.S. Renal Care Presents Analysis of VOICE Trial Demonstrating Favorable Safety Outcomes for Patients Treated with Vadadustat Versus an ESA During a Late-Breaking Session at American Society of Nephrology Kidney Week
NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries
Longeveron Announces Updated Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Palau Healthcare Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.